Medtronic InPen

Main article: Syringe pens and autoinjectors

2020: Medtronic InPen Insulin Syringe Announcement

In early December 2020, as a result of the strategic acquisition of Companion Medical, Medtronic released a smart insulin pen for patients with diabetes mellitus who have to take several injections a day.

The InPen smart pen is linked to the Guardian Connect continuous glucose monitoring system. The pooled data is sent to a smartphone app provided by Medtronic that lets you track insulin doses alongside real-time blood sugar readings. InPen can be used for a year in short-acting insulin injections. The company intends to add the possibility of introducing long-acting insulins in the future.

Medtronic InPen

Previously, the Companion app recorded the amount of insulin administered and allowed the calculation of bolus doses during meals. Medtronic officials said the app will continue to display information from other compatible glucose monitoring systems, but with a delay.

We were able to successfully combine a new smart pen and an old glucose monitoring device in just two months after the acquisition of Companion Medical, "said Sean Salmon, President of the Diabetes Division of Medtronic. - InPen can now be integrated with real-time glucose data, reflecting the full picture and allowing users to inject the right dose of insulin at the right time.

Medtronic announced the acquisition of Companion Medical in August 2020. Analysts called this deal a "bold step," which over time could bring the company $200 million in additional revenue, although Companion itself received only $11 million in sales of its products in 2019. The financial terms of the deposit were not disclosed.^[1]

Notes